£1.2M grant to tackle resistance to sheep scab treatments
Published: 19 June 2024
A research partnership has been awarded a £1.2M grant to explore the mechanism of resistance to the macrocyclic lactone injectables in the sheep scab mite
A research partnership has been awarded a £1.2M grant to explore the mechanism of resistance to the macrocyclic lactone (ML) injectables in the sheep scab mite, Psoroptes ovis, and how this resistance has spread across the UK. The three-year award, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), is led by The Moredun Research Institute, in collaboration with the University of Glasgow alongside Scotland’s Rural College (SRUC) and the Sustainable Control of Parasites in Sheep (SCOPS) Industry Group.
Sheep scab, a highly contagious disease caused by the ectoparasitic mite P. ovis., represents a significant welfare and economic concern for UK livestock production, costing the industry between £80-200 million annually. Current control strategies rely on organophosphate (OP) sheep dips and ML injectables (ivermectin, doramectin, and moxidectin).
However, overreliance on ML injectables for controlling gastrointestinal nematodes (GIN) and sheep scab has led to the emergence of ML-resistant parasites, posing a significant threat to sheep health and welfare. While OP dipping is an effective alternative, it is associated with more complex safety requirements for both operators and the environment and if overused scab mites could also develop resistance to OP.
Project lead, Dr Stew Burgess, Moredun Research Institute, said: “The £1.2 million award is a pivotal investment in our mission to combat the growing challenge of macrocyclic lactone resistance in the sheep scab mite, P. ovis. Sheep scab remains a significant threat to livestock health and welfare, imposing substantial economic burdens on farmers across the UK. With this funding, we aim to decode the genetic basis of resistance and its spread, providing the agricultural community with vital tools and updated strategies to manage this pervasive issue effectively.
“This project strengthens our collaborative efforts with partners at the University of Glasgow and SRUC and reinforces Moredun’s commitment to pioneering research that drives real-world impact.”
This new project will explore the mechanisms underlying ML resistance in P. ovis. The project aims to provide updated advice and guidelines on sheep scab management and develop novel diagnostic tools to track the spread of resistance, ensuring the optimum use of the available treatments.
To produce this new guidance, the project will use new tools, including samples of P. ovis mites that are either resistant or susceptible to ML treatment and a detailed map of their genes. The project team will study these samples to understand how ML resistance has developed and then track how this resistance has spread across the UK.
Dr Jenni McIntyre, from the University of Glasgow, said: “ML resistance is complex and poses a real challenge to farmers in controlling both GIN and scab. This exciting project will be the first to apply cutting-edge genomic tools to understand ML resistance in sheep scab mites.”
Lesley Stubbings, of SCOPS, said: “Maintaining two effective control methods is essential for our ability to control scab in the future. Understanding the basis of resistance in the MLs, together with the potential for early detection, will allow the industry to develop strategies to manage and slow resistance.”
Jack Hearn, from SRUC, said: “Translating basic research on the understanding of drug resistance in parasites to improve control strategies has undergone huge progress in recent years. We can now target parasites of veterinary importance like the mites that cause Sheep scab with a variety of research methods. This will lead to much swifter recommendations for improved scab management than previously possible to the benefit of animal welfare and farmers.”
Enquiries: ali.howard@glasgow.ac.uk or elizabeth.mcmeekin@glasgow.ac.uk
First published: 19 June 2024